tiprankstipranks
Waverley Pharma (TSE:WAVE)
:WAVE
Canadian Market
Holding TSE:WAVE?
Track your performance easily

Waverley Pharma (WAVE) Financial Statements

5 Followers

Waverley Pharma Financial Overview

Waverley Pharma's market cap is currently ―. The company's EPS TTM is C$-0.041; its P/E ratio is ―; Waverley Pharma is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 22.42K--$ 48.73K$ 96.09K
Gross Profit$ 14.58K--$ -48.82K$ 24.64K
EBIT$ -231.10K$ -308.17K$ -231.69K$ -1.30M$ -289.51K
EBITDA$ -201.76K$ -282.07K$ -205.59K$ -1.20M$ -182.94K
Net Income Common Stockholders$ -272.91K$ -344.83K$ -264.13K$ -1.33M$ -309.96K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 239.30K$ 55.16K$ 54.11K$ 53.02K$ 31.56K
Total Assets$ 1.78M$ 729.42K$ 838.45K$ 952.29K$ 2.04M
Total Debt$ 2.96M$ ―$ ―$ ―$ ―
Net Debt$ 2.72M$ ―$ ―$ ―$ ―
Total Liabilities$ 3.80M$ 2.47M$ 2.24M$ 2.09M$ 1.85M
Stockholders Equity$ -2.02M$ -1.74M$ -1.40M$ -1.14M$ 192.30K
Cash Flow-
Free Cash Flow$ 46.72K$ -250.32K$ -112.15K$ -482.41K$ -267.92K
Operating Cash Flow$ 46.72K$ -250.32K$ -112.15K$ -482.41K$ -267.92K
Investing Cash Flow$ -611.65K----
Financing Cash Flow$ 749.07K$ 251.37K$ 113.24K$ 503.87K$ 251.63K
Currency in USD

Waverley Pharma Earnings and Revenue History

Waverley Pharma Debt to Assets

Waverley Pharma Cash Flow

Waverley Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis